UK markets closed

AstraZeneca PLC (AZN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
54.58-1.73 (-3.07%)
At close: 04:00PM EDT
54.79 +0.21 (+0.38%)
After hours: 07:48PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 174.80B
Enterprise value 199.44B
Trailing P/E N/A
Forward P/E 13.93
PEG ratio (5-yr expected) 1.16
Price/sales (ttm)3.84
Price/book (mrq)4.71
Enterprise value/revenue 4.53
Enterprise value/EBITDA 28.08

Trading information

Stock price history

Beta (5Y monthly) 0.13
52-week change 3-7.05%
S&P500 52-week change 3-16.88%
52-week high 371.70
52-week low 353.63
50-day moving average 363.84
200-day moving average 362.68

Share statistics

Avg vol (3-month) 36.37M
Avg vol (10-day) 36.01M
Shares outstanding 53.1B
Implied shares outstanding 6N/A
Float 83.09B
% held by insiders 10.05%
% held by institutions 118.29%
Shares short (30 Aug 2022) 49.09M
Short ratio (30 Aug 2022) 41.51
Short % of float (30 Aug 2022) 4N/A
Short % of shares outstanding (30 Aug 2022) 40.29%
Shares short (prior month 28 Jul 2022) 413.64M

Dividends & splits

Forward annual dividend rate 41.45
Forward annual dividend yield 42.57%
Trailing annual dividend rate 32.90
Trailing annual dividend yield 35.15%
5-year average dividend yield 43.04
Payout ratio 4N/A
Dividend date 311 Sept 2022
Ex-dividend date 410 Aug 2022
Last split factor 22:1
Last split date 326 Jul 2015

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Jun 2022

Profitability

Profit margin -2.85%
Operating margin (ttm)17.08%

Management effectiveness

Return on assets (ttm)5.52%
Return on equity (ttm)-4.84%

Income statement

Revenue (ttm)44.04B
Revenue per share (ttm)14.34
Quarterly revenue growth (yoy)31.00%
Gross profit (ttm)27.61B
EBITDA 12.52B
Net income avi to common (ttm)-1.25B
Diluted EPS (ttm)-0.36
Quarterly earnings growth (yoy)-34.50%

Balance sheet

Total cash (mrq)4.89B
Total cash per share (mrq)1.58
Total debt (mrq)31.39B
Total debt/equity (mrq)87.31
Current ratio (mrq)0.96
Book value per share (mrq)11.60

Cash flow statement

Operating cash flow (ttm)7.62B
Levered free cash flow (ttm)3.99B